PharmaBizConnect to bridge gaps in the Indian pharma sector

PharmaBizConnect has been serving as one of its kind web portal for reducing the gap between pharma service providers and pharma professionals as well as entrepreneurs.
Apr 01, 2019 Mark

Press Release ( - Panchkula, Haryana - Apr 01, 2019 - The revised and improved online platform of PharmaBizConnect is one of the latest inclusions in the company’s list of achievements. Opened in 2014, PharmaBizConnect started as a web portal intended for connecting pharmaceutical service providers and service seekers on a single page. It has succeeded in providing the required boost to a vast majority of entrepreneurs in the pharma sector.

Over the years, PharmaBizConnect improved in terms of scope, and now the newly launched online platform would include functionalities for a wide assortment of pharma service providers including pharma contract manufacturers, third-party pharma contract manufacturing, PCD pharma companies, Ayurvedic pharma manufacturers and Ayurvedic herbal PCD Pharma Company. The newly launched platform of PharmaBizConnect has also been commended by pharma service seekers including startup professionals, enterprises or pharma professionals.

The primary objective of the online platform of PharmaBizConnect is to bridge the gap between pharma service providers and service seekers in a simple way. Service providers receive the opportunity to understand the requirements of service seekers in a better way interactively.

One of the striking features of the online platform of PharmaBizConnect is the facility for pharma service seekers to visit the website and search for service providers without having to make any payments. Visitors could connect with multiple pharma service providers and communicate with them directly regarding their concerns to find out the right solution.

Interestingly, the exhibitors or pharma service providers could also use the online platform of PharmaBizConnect without any cost. Exhibitors have to register their company on the platforms with the relevant details and information about the company and services. Exhibitors could leverage the notable benefits of the increase in revenue, access to new business opportunities, effective branding, global penetration and higher visibility of the business to visitors through PharmaBizConnect. The brand value of service providers would also improve due to the increased visibility provided by some visitors interacting with the service provider on the online platform of PharmaBizConnect.

The testimonials by users of PharmaBizConnect indicate the company’s effectiveness in its services. Director at Alardius Healthcare, Mukesh Yadav stated that “We can access pharma related inquiries from all over the country through PharmaBizConnect and make multiple conversions. I am very satisfied with the services provided on this unique online platform”. Director of Segos Biocare, Varun Puri commented, “I have been associated with PharmaBizConnect for only one year now, and it has helped me to accomplish my goals by providing genuine leads in the pharma franchise business.”

About The Company

PharmaBizConnect is not just your run of the third-party mill platform for connecting B2B businesses in the PCD pharma sector. PharmaBizConnect has been active for the last five years since 2014 and has helped a lot of PCD Pharma Companies in India to flourish their business. The company has also succeeded in the introduction of contemporary marketing techniques for different PCD Pharma Franchise in India.

Contact Information


Rajneesh Gupta

Phone: +917388111103



Source : Follow on Google News


Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login


If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.